<DOC>
	<DOC>NCT02027246</DOC>
	<brief_summary>The aim of this study was to study the effect of stem cell therapy on common symptoms of spinal cord injury patients.</brief_summary>
	<brief_title>Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury</brief_title>
	<detailed_description>Autologous bone marrow mononuclear cells are administered intrathecally by a standard procedure followed by standard rehabilitation therapy.</detailed_description>
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Diagnosed cases of any type of chronic Spinal cord injury Age above 6 months presence of acute infections such as Human immunodeficiency virus/ Hepatitis B Virus/ Hepatitis C Virus malignancies bleeding tendencies pneumonia renal failure severe liver dysfunction severe anemia [Hemoglobin &lt; 8] any bone marrow disorder other acute medical conditions such as respiratory infection pregnancy and lactation</criteria>
	<gender>All</gender>
	<minimum_age>8 Months</minimum_age>
	<maximum_age>63 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>spinal cord injury</keyword>
	<keyword>autologous bone marrow mononuclear cells</keyword>
	<keyword>stem cell therapy</keyword>
</DOC>